Antifibrinolytic therapy - locally-applied tranexamic acid (TXA) mouthwash/solution (SoF eligibility: TXA or EACA; all included trials used topical TXA) vs placebo or usual care
Major surgical complications · Percutaneous nephrolithotomy
Topical TXA showed no clear difference in major surgical complications compared with no TXA (placebo or usual care) (low certainty).
1 finding from 1 review
- RR 0.69 [0.45, 1.06]1 study · 400 participantsLow